Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:313-321
Published online before print December 30, 2002, doi: 10.1161/01.HYP.0000050650.52007.83
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/2/313    most recent
01.HYP.0000050650.52007.83v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cole, J. M.
Right arrow Articles by Bernstein, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cole, J. M.
Right arrow Articles by Bernstein, K. E.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow ACE/Angiotension receptors
Right arrow Genetically altered mice
Right arrow Hypertension - basic studies

(Hypertension. 2003;41:313.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Mice Lacking Endothelial ACE

Normal Blood Pressure With Elevated Angiotensin II

Justin M. Cole; Nata Khokhlova; Roy L. Sutliff; Jonathan W. Adams; Kevin M. Disher; Hui Zhao; Mario R. Capecchi; Pierre Corvol; Kenneth E. Bernstein

From the Department of Pathology, Emory University (J.M.C., N.K., R.L.S., J.W.A., K.M.D., H.Z., K.E.B.), Atlanta, Ga; Howard Hughes Medical Institute, Eccles Institute of Human Genetics, University of Utah (M.R.C.), Salt Lake City; and Institut National de la Santé et de la Recherche Medicale Unit 36, College de France (P.C.), Paris.

Correspondence to Ken Bernstein, MD, Room 7107A WMB, Department of Pathology, Emory University, Atlanta, GA 30322. E-mail kbernst{at}emory.edu

Recently, the concept of local renin-angiotensin systems (RAS) capable of generating angiotensin II apart from the circulation has received considerable attention. To investigate this, we generated ACE 1/3 mice in which one allele of ACE is null and the second allele was engineered to express ACE on the surface of hepatocytes. ACE 1/3 mice express no endothelial ACE and lack ACE within the lungs. Their kidneys contain <7.8% the enzyme levels present in control mice. Plasma conversion of angiotensin I to angiotensin II was 43.3% normal. The baseline blood pressure and renal function of the ACE 1/3 mice were normal, probably as a function of a marked increase of both plasma angiotensin I and angiotensin II. When exposed to 2 weeks of a salt-free diet (a stress diet stimulating the RAS), blood pressure in ACE 1/3 mice decreased to 92.3±2.0 mm Hg, a level significantly lower than that of wild-type control mice. The ACE 1/3 mice demonstrate the plasticity of the RAS and show that significant compensation is required to maintain normal, basal blood pressure in a mouse with an impaired local vascular and renal RAS.


Key Words: mice, knockout • angiotensin-converting enzyme • angiotensin II • endothelium • blood pressure




This article has been cited by other articles:


Home page
J EndocrinolHome page
J Manolopoulou, M Bielohuby, S J Caton, C E Gomez-Sanchez, I Renner-Mueller, E Wolf, U D Lichtenauer, F Beuschlein, A Hoeflich, and M Bidlingmaier
A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum
J. Endocrinol., February 1, 2008; 196(2): 215 - 224.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. D. Xiao, S. Fuchs, E. A. Bernstein, P. Li, D. J. Campbell, and K. E. Bernstein
Mice expressing ACE only in the heart show that increased cardiac angiotensin II is not associated with cardiac hypertrophy
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H659 - H667.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Hasegawa, S. Wakino, S. Tatematsu, K. Yoshioka, K. Homma, N. Sugano, M. Kimoto, K. Hayashi, and H. Itoh
Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2
Circ. Res., July 20, 2007; 101(2): e2 - e10.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. E. Bernstein
Views of the Renin-Angiotensin System: Brilling, Mimsy, and Slithy Tove
Hypertension, March 1, 2006; 47(3): 509 - 514.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Catarsi, R. Ravazzolo, F. Emma, D. Fruci, L. Finos, A. Frau, G. Morreale, A. Carrea, and G. M. Ghiggeri
Angiotensin-converting enzyme (ACE) haplotypes and cyclosporine A (CsA) response: a model of the complex relationship between ACE quantitative trait locus and pathological phenotypes
Hum. Mol. Genet., August 15, 2005; 14(16): 2357 - 2367.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. E. Bernstein, H. D. Xiao, K. Frenzel, P. Li, X. Z. Shen, J. W. Adams, and S. Fuchs
Six Truisms Concerning ACE and the Renin-Angiotensin System Educed From the Genetic Analysis of Mice
Circ. Res., June 10, 2005; 96(11): 1135 - 1144.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. J. Welch
Role of renal tissue angiotensin II in proximal tubule function
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F443 - F444.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. E. Bernstein, H. D. Xiao, J. W. Adams, K. Frenzel, P. Li, X. Z. Shen, J. M. Cole, and S. Fuchs
Establishing the Role of Angiotensin-Converting Enzyme in Renal Function and Blood Pressure Control through the Analysis of Genetically Modified Mice
J. Am. Soc. Nephrol., March 1, 2005; 16(3): 583 - 591.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Hashimoto, J. W. Adams, K. E. Bernstein, and J. Schnermann
Micropuncture determination of nephron function in mice without tissue angiotensin-converting enzyme
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F445 - F452.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Watanabe, T. A. Barker, and B. C. Berk
Angiotensin II and the Endothelium: Diverse Signals and Effects
Hypertension, February 1, 2005; 45(2): 163 - 169.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Daugherty, D. L. Rateri, H. Lu, T. Inagami, and L. A. Cassis
Hypercholesterolemia Stimulates Angiotensin Peptide Synthesis and Contributes to Atherosclerosis Through the AT1A Receptor
Circulation, December 21, 2004; 110(25): 3849 - 3857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. D. Xiao, S. Fuchs, D. J. Campbell, W. Lewis, S. C. Dudley Jr, V. S. Kasi, B. D. Hoit, G. Keshelava, H. Zhao, M. R. Capecchi, et al.
Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death
Am. J. Pathol., September 1, 2004; 165(3): 1019 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Zhou, W. P. Dirksen, G. J. Babu, and M. Periasamy
Differential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2797 - H2803.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. D. Xiao, S. Fuchs, K. Frenzel, J. M. Cole, and K. E. Bernstein
Newer Approaches to Genetic Modeling in Mice: Tissue-Specific Protein Expression as Studied Using Angiotensin-Converting Enzyme (ACE)
Am. J. Pathol., September 1, 2003; 163(3): 807 - 817.
[Full Text] [PDF]